NTKP note: The Independent Medical Alliance (IMA) was formerly known as the Front Line Critical Care Alliance (FLCCC).
By IMA, imahealth.org, 14th July 2025
What makes some people more vulnerable to vaccine harm?
This week, we’re highlighting new research and expert insights from IMA that explore that question in depth. From breakthrough studies to media roundups, here’s the latest you need to see, curated for those who value honest, independent science.
These resources are free to all, but not free to make. If you believe in independent, patient-centered science, consider standing with us. Donate to Our Mission.
Webinar: Spike Protein Susceptibility

Is vaccine harm predictable? This group of researchers thinks so.
In this IMA webinar, Dr. Paul Marik sits down with study authors Dr. James Thorp, Dr. Jack Tuszynski, and Matt Halma to explain what led them to investigate why some patients suffer after COVID-19 vaccination while others don’t. They break down the spike protein’s biological footprint, the cellular and hormonal factors that amplify its damage, and what this means for diagnosing and treating real people.
Explained: The Study Behind the Webinar
One-size-fits-all dosing may have been a fatal flaw.
A new peer-reviewed study in Advances in Virology, co-authored by IMA researchers, reveals why some people are far more vulnerable to spike protein harm than others. From genetic predisposition to batch variability, the findings dismantle the idea that COVID vaccines were equally safe for everyone. It’s a scientific reckoning with real consequences for treatment, policy, and how we define vaccine safety itself.
Dr. Tina Peers: Mast Cell Activation & Vaccine Injury

Dr. Tina Peers brings clinical insight to the spike injury conversation.
As a co-author of the new spike susceptibility study, Dr. Peers adds a vital layer of context. Grounded in her frontline experience treating Long COVID and vaccine-injured patients, she breaks down how genetics, hormones, nutrition, and a common yet overlooked condition—mast cell activation syndrome—can shape individual responses to the spike protein. Her perspective helps translate the science into actionable care.
Post-Vaccine Syndrome: Defining PACVS
New research gives a name (and validation) to vaccine injury.
In a study titled Breaking the Silence, IMA President Dr. Joseph Varon and Matthew Halma present hard evidence that Post-Acute COVID-19 Vaccination Syndrome (PACVS) is real, distinct, and measurable. Published in Heliyon, the paper pushes back against years of gaslighting and denial, offering patients scientific recognition and a path toward compassionate, evidence-based care.
Big Pharma Strikes Back: Media Roundup
Reform is gaining ground—and Big Pharma is pushing back.
As public pressure mounts for transparency and patient-first medicine, the pharmaceutical establishment is striking back. This roundup exposes a coordinated backlash: a leaked memo to discredit RFK Jr., a Moderna-linked attorney suing over HHS reforms, and the FDA’s quiet approval of Spikevax for infants. These aren’t isolated events, they’re signs of a system resisting change. IMA breaks down what’s happening, why it matters, and how we’re fighting back.
This research exists because people like you believe it should.
If you’ve found value in these studies, articles, or expert-led webinars, consider supporting our mission with a contribution. Your support powers the independent research that uncovers the truth about vaccine injury, helps vulnerable patients find answers, and brings science back to the service of health—not profit.
Every gift helps us keep publishing, keep asking the hard questions, and keep putting patients first.
Independent Medical Alliance
2001 L St NW Suite 500 | Washington, DC 20036
support@imahealth.org
CONTACT Independent Healthcare Alliance
MAILING ADDRESS
Independent Medical Alliance
2001 L St. NW Suite 500
Washington, DC 20036